Work

In adults with heart failure with preserved ejection fraction (HFpEF), does treatment with an SGLT2 inhibitor reduce heart-failure hospitalisation or cardiovascular mortality compared with standard therapy alone?

Year: 2026

Type: article

Abstract: SGLT2 inhibitors appear to reduce hospitalisations for heart failure in HFpEF patients, but their effect on cardiovascular mortality is less certain.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.19057147

Author: Tripdatabase

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7136172373

FWCI:

Cites:

Cited by:

Related to: 10